Amazon SES (Simple Email Service) is a scalable cloud-based email sending service that enables businesses to send marketing, notification, and transactional emails reliably and cost-effectively.
View Companies using Amazon SESMailchimp SPF is a DNS record that authorizes Mailchimp to send emails on your behalf, helping improve email deliverability and prevent spam or spoofing by verifying your domain's legitimacy.
View Companies using MailChimp SPFMailchimp is an all-in-one marketing platform that helps businesses design, send, and analyze email campaigns, automate marketing workflows, and grow their audience with easy-to-use tools and analytics.
View Companies using MailChimpA multinational company operates across multiple countries, leveraging global resources, markets, and talent to drive innovation, expand reach, and achieve competitive advantage worldwide.
View Companies using Multinational CompanyMandrill is a powerful transactional email API by Mailchimp, enabling developers to send personalized, automated emails securely and reliably, with detailed analytics and robust delivery tracking.
View Companies using MandrillThe decision makers in Forbion are Jasper Bos, Jennifer Fritzsche, Laura Hanooman-asbjornsen, etc. Click to Find Forbion decision makers emails.
Forbion specializes in investments within the life sciences sector, particularly in areas such as therapeutics, medical devices, and bioscience. The firm seeks to partner with innovative companies that are developing novel drugs and healthcare solutions, providing both capital and strategic support to help them succeed.
Forbion goes beyond just providing financial support. The firm offers a range of value-added services, including strategic guidance, operational support, and access to a broad network of industry experts. This holistic approach helps portfolio companies navigate challenges and accelerate their growth in the competitive life sciences landscape.
Forbion primarily operates in the life sciences industry, focusing on sectors such as therapeutics, medical devices, and healthcare. The firm is dedicated to fostering innovation in bioscience and supporting the development of groundbreaking medical solutions that can improve patient outcomes.
Yes, Forbion is open to partnering with startups in the life sciences sector. The firm looks for innovative companies with strong potential for growth and impact in their respective fields. Startups can apply for funding by reaching out to Forbion directly to discuss their business model and funding needs.
Forbion's investment strategy is centered around identifying and supporting high-potential companies in the life sciences sector. The firm typically invests in early to growth-stage companies that are developing innovative solutions in therapeutics, medical devices, and bioscience. Forbion aims to build long-term partnerships with its portfolio companies, providing not only capital but also strategic insights and operational expertise.
Forbion employs a rigorous evaluation process to assess potential investment opportunities. This includes analyzing the scientific and clinical validity of the technology, the market potential, the strength of the management team, and the overall business model. The firm also considers the competitive landscape and regulatory environment to ensure that the investment aligns with its strategic goals and has a high likelihood of success.
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 350M professionals from 40M companies with the right contact details.